Commentary

Introduction

Adcock Ingram is a leading South African manufacturer, marketer and distributor of a wide range of healthcare products. The Group enjoys a sizeable share of the private pharmaceutical market with a strong presence in over the counter (OTC) brands. The Group is South Africa’s largest supplier of hospital and critical care products and its footprint extends to other territories in sub-Saharan Africa and India. The Group’s extensive product portfolio includes branded and generic prescription medicines, OTC/fast moving consumer goods (FMCG) brands, intravenous solutions, blood collection products and renal dialysis systems.

Operational performance

The poor operational performance for the reporting period under review is regrettable and unfortunate. There are a number of sector specific reasons for the Group’s under-performance, not least, the generally negative market conditions during the period under review, margin pressures through an under recovery of increasing input and overhead costs,

read more

Downloads

Download booklet (PDF - 494KB)

 

 

Download presentation (PDF - 964KB)

 

 

View webcast

 

Financials

arrow Consolidated statements of comprehensive income
arrow Consolidated statement of changes in equity
arrow Consolidated statements of financial position
arrow Consolidated statements of cash flows
arrow Notes to the consolidated financial statements